期刊文献+

银屑病发病机理及药物治疗进展 被引量:9

Inducing Mechanism and Recent Cases of Drug Treatment for Psoriasis
下载PDF
导出
摘要 回顾近年来对银屑病病因和发病机理研究的以及用软化剂、角质促进剂、地蒽酚、焦油、外用皮质激素、维生素D3同类药、维A酸类、甲氨蝶呤、环孢素、他克莫司和PUVA疗法抗银屑病治疗的进展。 The pathogenesis and treatment of psoriasis are reviewed. Topical treatments consist of emollients and keratolytic agents, anthralin, coal tar, corticosteroids, vitamin D3 analogues, topical retinoids, and topical psoralens plus ultraviolet A light, In patients who do not respond adequately to topical therapy, oral or injectable therapy, such as oral retiniods, methotrexate, cyclosporine, tacrolimus, and oral psoralens plus UVA light, may be warranted.
出处 《抗感染药学》 2006年第3期97-101,共5页 Anti-infection Pharmacy
关键词 银屑病 发病机理 药物治疗 Psoriasis pathogenesis drug treatments
  • 相关文献

参考文献26

  • 1[1]Peters BP.Pathophysiology and treatment of psoriasis[J].A J Hosp,2000,57(7):645-646.
  • 2[2]Han N,Nowakowski P,West D.Common skin disorders:Acne and psoriasis[A].In:Dipiro J.Talbert RL,Yee GC,et al.Pharmacotherapy[M].Stamford,CT.Appleton & Lange,1999:1489-1504.
  • 3[3]Cather JC,Menter A.Combining traditional agents and biologics for the treatment of psoriasis[J].Semin Cutan Med Surg,2005,24(1):37-45.
  • 4[4]Lebwohl M.A clinician's paradigm in the treatment of psoriasis[J].J Am Acad Dermatol,2005,53(suppl 1):59-69.
  • 5[5]Bardolph E,Ashton R.Psoriasis:a review of present and future management[J].Nurs Stand,1998,12 (21):43-47.
  • 6[6]Muller K.Antipsoriatic and proinflammatory action of anthralin[J].Biochem Pharmacol,1997,53:1215-1221.
  • 7[7]Stern RS.Psoriasis[J].Lancet,1997,350:349-353.
  • 8[8]Arnold WP.Tar[J].Clin Dermatol,1997,15:723-737.
  • 9[9]McClelland PB.New treatment options for psoriasis[J].Dermatol Nurs,1997,9:295-304.
  • 10[10]Hughes J,Rustin M.Corticosterioids[J].Clin Dermatol,1997,15:715-721.

同被引文献109

引证文献9

二级引证文献45

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部